Collaboration with Dynavax West Pharmaceutical Services partnering with Dynavax Technologies Corporation for the manufacture and supply of syringe stoppers for the HEPLISAV-B vaccine presents a sales opportunity to explore collaborations with other vaccine manufacturers for similar products.

Market Expansion at Pharmapack The launch of Daikyo PLASCAP closures at the Pharmapack event showcases West's innovation. Leveraging this platform, there is potential to expand market reach by introducing the product to more pharmaceutical companies and attendees of such industry events.

Financial Success in Q4 The revenue and earnings exceeding estimates in Q4 positions West as a reliable partner for drug manufacturers. This financial success can be leveraged to attract new clients looking for trusted suppliers in the pharmaceutical manufacturing industry.

Board Expansion with Janet Haugen Appointing Janet Haugen to the Board of Directors enhances West's leadership and credibility. This strategic move can be highlighted to showcase a diverse and experienced leadership team, potentially attracting businesses looking for partners with strong governance.

Investor Conference Participation Participating in events like the CJS Annual Investor Conference allows West to increase visibility among potential investors and partners. Engaging with attendees and presenting innovative solutions can lead to new business opportunities and investments in the company.